TY  - JOUR

T1  - Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.

JO  - Expert Rev Pharmacoecon Outcomes Res

PY  - 2009/10/01

AU  - Ara R

AU  - Rafia R

AU  - Ward SE

AU  - Wierzbicki AS

AU  - Reynolds TM

AU  - Rees A

AU  - Pandor A

ED  - 

DO  - DOI: 10.1586/erp.09.42

VL  - 9

IS  - 5

SP  - 423

EP  - 433

Y2  - 2024/12/22

ER  -